Worried about your symptoms?
Start the Medullary Thyroid Cancer test with our free AI Symptom Checker.
This will help us personalize your assessment.
By starting the symptom checker, you agree to the Privacy Policy and Terms of Use
Hoarse voice
Swallowing difficulties
Lymph swollen
Swelling in the neck
Face is swollen
I have a lump in my neck
Shortness of breath
Not seeing your symptoms? No worries!
With a free 3-min Medullary Thyroid Cancer quiz, powered by Ubie's AI and doctors, find possible causes of your symptoms.
This questionnaire is customized to your situation and symptoms, including the following personal information:
Biological Sex - helps us provide relevant suggestions for male vs. female conditions.
Age - adjusts our guidance based on any age-related health factors.
History - considers past illnesses, surgeries, family history, and lifestyle choices.
Your symptoms
Our AI
Your report
Your personal report will tell you
✔ When to see a doctor
✔︎ What causes your symptoms
✔︎ Treatment information etc.
See full list
Medullary thyroid cancer is an unusual type of cancer of the thyroid, which is an organ in the front of the neck. The cause of medullary carcinoma is unknown but is sometimes due to inherited gene mutations. Workup includes scans, ultrasound, biopsy and a specific lab test called calcitonin.
Your doctor may ask these questions to check for this disease:
Medullary thyroid cancer's primary treatment is complete surgical removal of the thyroid and surrounding structures. If it has spread beyond the neck, chemotherapy, radiotherapy, immunotherapy, or targeted drug therapies may be recommended as well.
Reviewed By:
Robin Schoenthaler, MD (Oncology)
Board certified radiation oncologist with over 30 years experience treating cancer patients. Senior physician advisor for expert medical options in adult oncology. Published award-winning essayist on medical and health issues and more.
Hidetaka Hamasaki, MD (Endocrinology)
Dr. Hamasaki graduated from the Hiroshima University School of Medicine and the Graduate School of Medicine, Jichi Medical University. He completed his residency at the Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Hospital and the Department of Internal Medicine, Kohnodai Hospital, National Center for Global Health and Medicine. He has served in the National Center for Global Health and Medicine Hospital and Kohnodai Hospital and joined Hamasaki Clinic in April 2017. Dr. Hamasaki specializes in diabetes and treats a wide range of internal medicine and endocrine disorders.
Content updated on Mar 31, 2024
Following the Medical Content Editorial Policy
Was this page helpful?
Viola D, Elisei R. Management of Medullary Thyroid Cancer. Endocrinol Metab Clin North Am. 2019 Mar;48(1):285-301. doi: 10.1016/j.ecl.2018.11.006. Epub 2018 Dec 26. PMID: 30717909.
https://www.sciencedirect.com/science/article/abs/pii/S0889852918305930?via%3DihubCancer of the Thyroid - AMERICAN THYROID ASSOCIATION
https://www.thyroid.org/medullary-thyroid-cancer/Current Guidelines for Management of Medullary Thyroid Carcinoma
https://www.e-enm.org/journal/view.php?doi=10.3803/EnM.2021.1082Reviewed By:
Robin Schoenthaler, MD (Oncology)
Board certified radiation oncologist with over 30 years experience treating cancer patients. Senior physician advisor for expert medical options in adult oncology. Published award-winning essayist on medical and health issues and more.
Hidetaka Hamasaki, MD (Endocrinology)
Dr. Hamasaki graduated from the Hiroshima University School of Medicine and the Graduate School of Medicine, Jichi Medical University. He completed his residency at the Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Hospital and the Department of Internal Medicine, Kohnodai Hospital, National Center for Global Health and Medicine. He has served in the National Center for Global Health and Medicine Hospital and Kohnodai Hospital and joined Hamasaki Clinic in April 2017. Dr. Hamasaki specializes in diabetes and treats a wide range of internal medicine and endocrine disorders.
Our symptom checker AI is continuously refined with input from experienced physicians, empowering them to make more accurate diagnoses.
“World’s Best Digital
Health Companies”
Newsweek 2024
“Best With AI”
Google Play Best of 2023
“Best in Class”
Digital Health Awards 2023 (Quarterfinalist)
Which is the best Symptom Checker?
Ubie’s symptom checker demonstrated a Top-10 hit accuracy of 71.6%, surpassing the performance of several leading symptom checkers in the market, which averaged around 60% accuracy in similar assessments.
Link to full study:
https://www.medrxiv.org/content/10.1101/2024.08.29.24312810v1